{"id":"https://openalex.org/A5111809377","orcid":null,"observed_orcids":[],"display_name":"Fran\u00e7ois\u2010Xavier Mathy","raw_author_names":["F.-X. Mathy","F.\u2010X. Mathy","Francois-Xavier Mathy","Francois\u2010Xavier Mathy","Fran\u00e7ois-Xavier Mathy","Fran\u00e7ois-xavier Mathy","Fran\u00e7ois\u2010Xavier Mathy"],"full_name":"Fran\u00e7ois\u2010Xavier Mathy","works_count":21,"cited_by_count":1082,"summary_stats":{"2yr_mean_citedness":3.0,"h_index":13,"i10_index":15},"ids":{"openalex":"https://openalex.org/A5111809377","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I85722119","ror":"https://ror.org/01n029866","display_name":"UCB Pharma (Belgium)","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]},"years":[2023,2022,2019,2018,2016,2015,2013,2009,2007]},{"institution":{"id":"https://openalex.org/I95674353","ror":"https://ror.org/02495e989","display_name":"UCLouvain","country_code":"BE","type":"education","lineage":["https://openalex.org/I95674353"]},"years":[2007,2005,2004,2003,2001]},{"institution":{"id":"https://openalex.org/I99464096","ror":"https://ror.org/05f950310","display_name":"KU Leuven","country_code":"BE","type":"education","lineage":["https://openalex.org/I99464096"]},"years":[2003]}],"last_known_institutions":null,"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","count":8,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","count":5,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","count":4,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","count":4,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","count":3,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12569","display_name":"Restless Legs Syndrome Research","value":5.52e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10704","display_name":"Advancements in Transdermal Drug Delivery","value":2.85e-05,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","value":2.41e-05,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","value":1.86e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","value":1.7e-05,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"x_concepts":[{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.96800696849823},{"id":"185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","score":0.9080044031143188},{"id":"98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","score":0.8356705904006958},{"id":"112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","score":0.8123795390129089},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.38378632068634033}],"counts_by_year":[{"year":2001,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2003,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2004,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2005,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2007,"works_count":2,"oa_works_count":1,"cited_by_count":0},{"year":2009,"works_count":2,"oa_works_count":0,"cited_by_count":0},{"year":2012,"works_count":0,"oa_works_count":0,"cited_by_count":21},{"year":2013,"works_count":1,"oa_works_count":1,"cited_by_count":32},{"year":2014,"works_count":0,"oa_works_count":0,"cited_by_count":28},{"year":2015,"works_count":3,"oa_works_count":2,"cited_by_count":41},{"year":2016,"works_count":1,"oa_works_count":0,"cited_by_count":58},{"year":2017,"works_count":0,"oa_works_count":0,"cited_by_count":65},{"year":2018,"works_count":1,"oa_works_count":1,"cited_by_count":61},{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":52},{"year":2020,"works_count":0,"oa_works_count":0,"cited_by_count":71},{"year":2021,"works_count":1,"oa_works_count":0,"cited_by_count":75},{"year":2022,"works_count":1,"oa_works_count":1,"cited_by_count":85},{"year":2023,"works_count":2,"oa_works_count":2,"cited_by_count":70},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":95},{"year":2025,"works_count":1,"oa_works_count":1,"cited_by_count":88},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":52}],"display_name_alternatives":["F.-X. Mathy","F.\u2010X. Mathy","Francois-Xavier Mathy","Francois\u2010Xavier Mathy","Fran\u00e7ois-Xavier Mathy","Fran\u00e7ois-xavier Mathy","Fran\u00e7ois\u2010Xavier Mathy"],"block_key":"f mathy","works_api_url":"https://api.openalex.org/works?filter=author.id:A5111809377","updated_date":"2026-11-04T11:47:51","created_date":"2016-06-24T00:00:00"}